SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-042521
Filing Date
2023-08-14
Accepted
2023-08-14 17:01:24
Documents
50
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tcon-20230630.htm   iXBRL 10-Q 2550909
2 EX-31.1 tcon-ex31_1.htm EX-31.1 14339
3 EX-31.2 tcon-ex31_2.htm EX-31.2 13977
4 EX-32.1 tcon-ex32_1.htm EX-32.1 9771
5 EX-32.2 tcon-ex32_2.htm EX-32.2 9384
  Complete submission text file 0000950170-23-042521.txt   7474813

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tcon-20230630_def.xml EX-101.DEF 138329
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tcon-20230630_cal.xml EX-101.CAL 29764
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcon-20230630_pre.xml EX-101.PRE 230050
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcon-20230630_lab.xml EX-101.LAB 323343
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcon-20230630.xsd EX-101.SCH 44994
44 EXTRACTED XBRL INSTANCE DOCUMENT tcon-20230630_htm.xml XML 1251944
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

IRS No.: 342037594 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36818 | Film No.: 231171748
SIC: 2836 Biological Products, (No Diagnostic Substances)